The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
The initiative was announced at World Hypertension Congress, Chennai
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Enables millions of Indians to monitor their vitals without the need of any additional device
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Subscribe To Our Newsletter & Stay Updated
